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Abstract
Background: Neuropeptides are cell to cell signalling molecules that regulate many critical biological processes
including development, growth and reproduction. These peptides result from the complex processing of
prohormone proteins, making their characterization both challenging and resource demanding. In fact, only 42
neuropeptide genes have been empirically confirmed in cattle. Neuropeptide research using high-throughput
technologies such as microarray and mass spectrometry require accurate annotation of prohormone genes and
products. However, the annotation and associated prediction efforts, when based solely on sequence homology
to species with known neuropeptides, can be problematic.
Results: Complementary bioinformatic resources were integrated in the first survey of the cattle neuropeptide
complement. Functional neuropeptide characterization was based on gene expression profiles from microarray
experiments. Once a gene is identified, knowledge of the enzymatic processing allows determination of the final
products. Prohormone cleavage sites were predicted using several complementary cleavage prediction models
and validated against known cleavage sites in cattle and other species. Our bioinformatics approach identified 92
cattle prohormone genes, with 84 of these supported by expressed sequence tags. Notable findings included an
absence of evidence for a cattle relaxin 1 gene and evidence for a cattle galanin-like peptide pseudogene. The
prohormone processing predictions are likely accurate as the mammalian proprotein convertase enzymes, except
for proprotein convertase subtilisin/kexin type 9, were also identified. Microarray analysis revealed the differential
expression of 21 prohormone genes in the liver associated with nutritional status and 8 prohormone genes in the
placentome of embryos generated using different reproductive techniques. The neuropeptide cleavage prediction
models had an exceptional performance, correctly predicting cleavage in more than 86% of the prohormone
sequence positions.
Conclusion: A substantial increase in the number of cattle prohormone genes identified and insights into the
expression profiles of neuropeptide genes were obtained from the integration of bioinformatics tools and
database resources and gene expression information. Approximately 20 prohormones with no empirical evidence
were detected and the prohormone cleavage sites were predicted with high accuracy. Most prohormones were
supported by expressed sequence tag data and many were differentially expressed across nutritional and
reproductive conditions. The complete set of cattle prohormone sequences identified and the cleavage prediction
approaches are available at http://neuroproteomics.scs.uiuc.edu/neuropred.html.
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Background
Neuropeptides are a diverse class of signalling peptides
that include neurotransmitters and peptide hormones
that have various paracrine, endocrine, and autocrine
effects [1,2]. Neuropeptides support cell to cell communi-
cation and regulate diverse biological processes such as
blood flow, synaptogenesis, memory, learning, reproduc-
tion, lactation, development, growth, feeding, behavior
and cell morphology [1,2]. Only 42 neuropeptide-con-
taining genes, appreciably fewer than the expected
number, have been empirically confirmed in cattle tis-
sues. Annotating the cattle neuropeptide complement is
important as these molecules play a critical role in cattle
production, health and well-being. For example, cattle
neuropeptide Y (NPY) stimulates food intake, oxytocin
stimulates smooth muscle contraction, vasopressin stimu-
lates water re-absorption in the kidney, and ghrelin stim-
ulates appetite and feeding activity through interactions
with NPY and other peptides [3]. Genetic variation in cat-
tle neuropeptide genes has been associated with variation
in traits of economical importance including birth weight,
average daily gain, body weight, feed conversion ratio, rib-
eye area, marbling score and subcutaneous fat depth [4-
7].
The annotation of neuropeptides will aid functional stud-
ies that use high-throughput transcriptomic (e.g., micro-
array) and proteomic (e.g., 2D gels, mass spectrometry)
techniques. Several microarray platforms derived from the
cattle genome and expressed sequence tag (EST) databases
(e.g., NCBI Gene Expression Omnibus or GEO [8]) are
available such as GEO platforms GPL2853, GPL2864,
GPL3301, GPL3810, GPL6497, GPL2112, and GPL1854.
These platforms include a variable number of probes that
map to neuropeptide-containing genes. However, the
incomplete annotation of the cattle neuropeptide com-
plement has hindered the ability to characterize the
expression profiles of neuropeptide-containing genes.
Experimental confirmation of neuropeptides and experi-
mental peptidome studies are resource intensive [2,9-11].
Although neuropeptides can be biochemically character-
ized using mass spectrometry, such efforts are considera-
bly enhanced by the addition of neuropeptide-containing
gene annotations that allows the association of mass spec-
tral peaks with specific peptides [2].
Annotating the neuropeptide complement is complicated
because neuropeptides are derived from larger proteins by
a complex series of post-translational modifications.
Translation of the neuropeptide-containing gene gener-
ates a large protein known as a preproneuroptide or pre-
prohormone, which conceptually consists of a signal
peptide region and a region that contains one or more
peptides. The signal peptide is removed by signal pepti-
dases to form the proneuropeptide or prohormone (here-
inafter referred to as prohormone) [1,2,12]. The
prohormone may undergo further cleavage by other pro-
teases, notably proprotein or prohormone proteases, at
basic amino acids (Arg or Lys) [1,2,12]. After cleavage, the
terminal basic amino acids are typically removed by car-
boxylases or Arg/Lys aminopeptidases and various addi-
tional post-translational modifications (e.g., amidation,
glycosylation) can occur before the final bioactive neu-
ropeptides are produced [1,2,12]. The resulting bioactive
neuropeptides are often small, typically between 3 to 40
residues long [1,2].
Prohormone processing is also highly dependent on the
environment (e.g., pH), prohormone structural proper-
ties, alternative splicing, presence of specific proteases or
proteases with different affinity for cleavage [1,2,12,13].
Furthermore, the presence of neuropeptides varies across
species, tissues, developmental stages, and with other con-
ditions [1,2,12]. Accordingly, experimental detection of
neuropeptides in mammals has been limited to only a few
species (notably human, mouse and rat) and neuropep-
tide families such as insulin.
There are two distinct phases in the process of annotating
the neuropeptide complement of a species. The first phase
requires the identification of the prohomone genes. Pro-
hormones and neuropeptides frequently have different
lengths across species and a very short conserved region
that interacts with its cognate receptor [1,2]. As a conse-
quence, the prohormone may contain large and highly
variable sections that show limited homology to well-
studied species. Therefore, while the prohormone gene in
one species may be identified by sequence homology to
another better studied species, homology alone is insuffi-
cient to accurately annotate the actual neuropeptides
within the prohormone sequence. The second phase of
the annotation process involves the identification of neu-
ropeptides within the prohormone and this requires the
prediction of the prohormone cleavage sites. Accurate pre-
diction of prohormone cleavage sites and resulting pep-
tides has been achieved using machine learning
techniques such as logistic regression, artificial neural net-
works, support vector machines and memory-based rea-
soning [14-18].
The availability of the cattle genome sequence provides an
unprecedented opportunity to conduct a comprehensive
identification of cattle neuropeptide genes using comple-
mentary bioinformatic tools, databases and information
resources. The goal of this study was to compile and char-
acterize the cattle prohormone genes and neuropeptide
complement. First, prohormone genes were located on
the recently published cattle genome sequence [19] using
a strategy that integrates information from complemen-
tary genomic databases [18]. This strategy addressed theBMC Genomics 2009, 10:228 http://www.biomedcentral.com/1471-2164/10/228
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situation where the initial automated annotation failed to
detect genes or detected only partial sequences. Second,
biological evidence for predicted prohormone genes was
obtained from public genomic and EST databases. Third,
the prohormone genomic census was used to accurately
annotate cattle microarray platforms and subsequently to
assess the presence and differential expression of neu-
ropeptide genes in microarray experiments. Lastly,
machine and statistical learning tools were applied to our
database of prohormone gene sequences to predict pro-
hormone cleavage sites and resulting peptides. The result-
ing catalogue also benefits neuropeptide annotation in
other ungulate and mammalian livestock species that do
not have sequenced genomes. Our integrative bioinfor-
matics strategy can be applied to annotate the neuropep-
tide complements in other species that have comparable
genomic and transcriptomic information.
Methods
Neuropeptide prohormone identification and 
characterization
To detect prohormone genes in cattle, a list of candidate
prohormone genes was generated from multiple sources
including public databases and the literature. First, the
mammalian (primarily human, mouse, rat, and cattle)
prohormone genes used by Amare et al. [15] and Tegge et
al. [17] were combined. Additional prohormone genes
were identified from the UniProt database release 14.0
[20] using the protein family field and a search using neu-
ropeptide-like characteristics such as hormone or neu-
ropeptide molecular functions. The SwePep database [21]
was also used to supplement the list of candidate prohor-
mone genes because it focuses on small peptides detected
by mass spectrometry.
Candidate genes were searched for in the cattle genome
Btau_3.1 assembly using the sequence alignment tool
BLAST [22] following the approach described by Southey
et al. [18]. The search was conducted using the NCBI
BLAST standalone version 2.18 with default parameters
(E-value of 10 and BLOSUM62 scoring matrix) and disa-
bled filtering. The BLAST results from each prohormone
were screened based on the alignment score and E-value
to identify the most likely matches and location of the cor-
responding cattle prohormone gene in the genome. In
addition, results were examined for multiple homologous
prohormone genes that could indicate gene duplication
events in the cattle genome. The protein prohormone
sequences were identified within the detected genome
regions using the gene parsing tool Wise2 [23]. Wise2 pre-
dicts the gene structure using a gene prediction model that
includes introns and frameshift errors based on a target
protein sequence and a genomic DNA sequence. The tar-
get protein sequences were selected from the candidate list
with a preference for cattle or sheep genes. The genomic
region encompassing the BLAST match was extended
approximately 500 base pairs to the 5' and 3' ends of the
match. Each predicted prohormone gene was compared
to the UniProt and Entrez Gene [24] databases to assess
the accuracy of the prediction based on previously
reported prohormone genes. The predicted protein
sequence was then compared to the corresponding pub-
lished sequences using the multiple sequence alignment
tool, Clustalw [25]. This step also served to confirm the
suitability of the Wise2 prediction. If a suitable prediction
was not obtained from the extended genomic region, pro-
tein sequences from other species were also used. Raw
genomic data (including unassigned genomic regions,
whole genome shotgun sequencing and trace archives)
were also searched when there was no suitable BLAST
match to a candidate or when the alignment to the
genome assembly indicated a missing genomic region.
This strategy allowed the annotation of genomic regions
that were partly or not included in the assembly. The more
recent Btau_4.0 assembly [26] and University of Maryland
assembly 1.5 (UMD_1.5; ftp://ftp.cbcb.umd.edu/pub/
data/assembly/Bos_taurus/UMD_Freeze1.5/)[27], which
became available during the annotation process, were
used to identify remaining prohormone genes not found
in the Btau_3.1 assembly.
Expressed sequence tag information
The comprehensive identification of prohormone genes
in the cattle genome constitutes the first step toward a
comprehensive characterization of the neuropeptide gene
set. However, prediction of prohormone gene sequences
is insufficient evidence of the actual presence and expres-
sion of these genes. Reported cattle ESTs provide inde-
pendent support for prohormone genes, especially for the
unpublished cattle prohormone genes. The candidate
genes were searched for on the UniGene database (build
#92) and information on the ESTs (number of ESTs,
sequence, overlap) and tissue of expression were extracted
from the database for each cattle prohormone gene. This
search was complemented with searches for candidate
genes on the NCBI EST (dbEST release 080107) and NCBI
Nucleic databases to encompass any cattle ESTs and
nucleic acid sequences that were not included in the avail-
able UniGene release.
Transcriptomic analysis
A comprehensive characterization of neuropeptide gene
expression profiles was attained by querying and analyz-
ing two complementary resources. First, a survey of gene
expression records across tissues and developmental
stages available in the UniGene and EST databases was
performed. This survey offered an introductory glimpse at
the expression patterns of prohormone genes. However,
the nature of the UniGene data-spanning experiments,
most with no connecting samples, prevents the profilingBMC Genomics 2009, 10:228 http://www.biomedcentral.com/1471-2164/10/228
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and relative quantification of prohormone gene expres-
sion. To address this, a second resource, the NCBI GEO
database, was inspected for informative microarray stud-
ies. Consideration was given to experiments that included
at least five biological replicates per condition and two
technical replicates per sample and that used a platform
with at least 50% of the identified cattle prohormone
genes. These requirements ensured a minimum accuracy
on the detection of prohormone gene expression and pre-
cision on the profile estimates.
Two large microarray investigations met these criteria and
were selected for examination of the presence of neu-
ropeptides and for evidence of differential expression
between conditions. The first, reported by Loor et al. [28],
consisted of liver samples from healthy cows and those
exposed to a nutritional plane conducive to ketosis. The
second, reported by Everts et al. [29], consisted of placen-
tome samples of pregnancies from calves obtained using
three reproductive techniques: in vitro fertilization (IVF),
somatic cell nuclear transfer (NT) and artificial insemina-
tion (AI). Both experiments used the same cattle microar-
ray platform, GEO platform GPL2853, which has 13,257
70-oligomer elements printed in duplicate. The microar-
ray platform contained 45 known cattle prohormone
genes with the complete gene sequence available, two
prohormone genes with only a partial sequence previ-
ously reported, and nine previously unreported prohor-
mone genes. The platform also contained the sequence of
a probe (OLIGO_09208) that spans a splice site of the
torsin family 2 member A (TOR2A) gene. Due to the loca-
tion of this splice site, this oligomer represents the TOR2A
isoform 1 ([Swiss-Prot:A4FUH1]) that is not a prohor-
mone and not the TOR2A  isoform 4 (Swiss-
Prot:P0C7W1), which is the prohormone that produces
salusin neuropeptides in other mammals [30]. However,
this microarray element was considered a probe for the
prohormone gene due to possible cross-hybridization of
the TOR2A isoform 4 to the region of the probe prior to
the splice site.
The microarray data filtering, normalization and analyses
used in this study were the same as described in Loor et al.
[28] and Everts et al. [29], respectively. Briefly, fluores-
cence data processing encompassed the filtering of spots
marked as unreliable by the scanning software or weak
(when compared to control elements) and loess normali-
zation before fitting a two-stage, mixed-model analysis. In
the first stage, gene expression values were adjusted for
global dye and microarray effects and in the second stage,
the expression of each microarray element was described
with a model including the effects of dye-, sample-, micro-
array- and experimental-specific factors. Only the patterns
of prohormone gene expression across health status [28]
and embryo type [29] are reported here. The statistical sig-
nificance of the differential expression was adjusted for
multiple testing across neuropeptide genes using the false
discovery rate approach [31].
Prediction of cleavage sites
The cleavage sites of all prohormone genes were predicted
using logistic regression and artificial neural network
models developed using 42 cattle prohormone sequences
[17] in NeuroPred [32]. Prior to prediction, the signal
peptide and known cleavage sites were identified based
on experimental evidence from the UniProt record when
available. When no experimental evidence was available,
the signal peptide length was predicted using SignalP [33]
and cleavage sites were assigned based on homology to
known cleavage sites from other species.
Results and Discussion
Prohormone identification
There were 92 candidates for cattle prohormone genes
identified from the literature and protein databases and
these included 42 cattle prohormone genes with empirical
evidence. The bioinformatics search identified 92 cattle
prohomone genes that included a novel calcitonin gene
but failed to identify one candidate. Table 1 presents the
distribution of the cattle prohormone genes with com-
plete and partial sequences that were identified in the cat-
tle genome across the nucleic and protein resources used
to detect the genes. A detailed description of the 92 pro-
hormone genes with supporting evidence from the Entez
Gene, Unigene and UniProt databases is provided [see
Additional file 1]. The protein sequences of the discovered
prohormone genes with cleavage sites identification is
provided in the format used by NeuroPred [see Additional
file 2].
The initial BLAST query to the Btau_3.1 assembly indi-
cated that 88 prohormone gene candidates were likely to
be present (E-value < 10-6). The complete sequences of 80
cattle prohormone genes were subsequently obtained by
using Wise2 with the Btau_3.1 assembly. The remaining
eight candidates with strong BLAST evidence were located
in the genome but had incomplete sequences in the
Btau_3.1 assembly. Complete sequences for six candi-
dates, including five that have been previously reported
with complete sequences, were recovered using the recent
Btau_4.0 and UMD_1.5 assembly. Of the remaining two
candidates with strong BLAST evidence, the secretin gene
(SECR) including the reported cattle secretin peptide
([Swiss-Prot:P63296]) was not recovered due to incom-
plete coverage of the genomic region based on the
sequence available (Dr. Steven Salzberg, Dr. Liliana Florea
and Finn Hanrahan, personal communication), and
sequence characteristics (discussed below) suggested that
galanin-like peptide gene (GALP) is a pseudogene (dis-
cussed below). In addition, three candidate genes, cocaineBMC Genomics 2009, 10:228 http://www.biomedcentral.com/1471-2164/10/228
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and amphetamine responsive transcript (CART), peptide
YY (PYY) and seminalplasmin or peptide YY2 (PYY2),
have published cattle sequences and were recovered using
the UMB_1.5 assembly because there were no significant
matches (E-value > 1) to the Btau_3.1 and Btau_4.0
assemblies.
Of the detected genes available in UniProt, 56 prohor-
mone genes have complete and annotated sequences, 16
prohormone genes have complete sequences without
annotation, four prohormone genes have complete
sequences but have only been reported as fragments
(three in SwissProt and one in TrEMBL), and nine new
prohormone genes have complete sequences previously
unreported (not reported in UniGene) in cattle (Table 1).
A comparison of genomic and reported sequences showed
that 14 prohormone genes had different sequences due to
single nucleotide polymorphisms, two prohormone genes
had undetermined amino acids, and adenylate cyclase
activating polypeptide 1 (ADCYAP1) includes an appar-
ently incorrect sequence. The predicted amino acid
sequence of the ADCYAP1 prohormone gene was more
consistent (higher percentage of identity and similarity)
with other species than the cattle SwissProt sequence
([Swiss-Prot:Q29W19]). The available UniProt protein
sequence for cattle TOR2A does not include the isoform
corresponding to the alpha-salusin and beta-salusin neu-
ropeptides that was found in this study.
The use of complementary nucleotide databases was criti-
cal to validate the complete set of predicted prohormone
genes. There were 81 prohormone sequences with cattle
ESTs in the UniGene database and two prohormone
genes, relaxin 3 (RLN3, [GenBank:BI682322] and neu-
ropeptide W, (NPW; [GenBank:DY084317]), with cattle
ESTs not included in UniGene. In addition, the full DNA
sequence of cattle islet amyloid polypeptide gene (IAPP;
[GenBank:AJ675853]) was not present in UniGene.
Although a cattle gonadotropin-releasing hormone 2
(GON2) was detected, the lack of EST data may support
the finding that this gene is functionally inactive [34]. Our
approach predicted adrenomedullin 2 (ADM2), neurome-
din U (NMU), tuberoinfundibular 39 residue protein
(TIP39) and tachykinin 4 (TAC4) prohormone genes with
complete sequences but without cattle EST data. This con-
stitutes important findings because molecular techniques
that rely on EST information (e.g., the design of microar-
ray platforms or primers when there is no genome infor-
mation available) will not be able to detect these genes.
Multiple genomic matches to the candidate query
sequences can uncover gene duplication events. Species-
specific neuropeptide prohormone variants resulting
from duplication have been reported in other mammalian
species. Examples include insulin-like 4 gene (INSL4) in
humans and chimpanzees [35], hepcidin antimicrobial
peptide 2 gene (HEPC2) in mouse [36], and two variants
of insulin gene (INS) found in various rodents including
rat and mouse [37]. In all previous cases, the searches
resulted in a single match to a single cattle prohormone,
indicating that there was no support for duplicated genes
or cattle-specific prohormone genes. With the exception
of the calcitonin family, the examination of additional
BLAST matches provided no evidence for duplicated pro-
hormone genes in the cattle genome that were not previ-
ously expected based on homology to protein families
(e.g., the insulin family). Our approach uncovered a
potential duplication in the calcitonin family because it
Table 1: Distribution of the candidate prohormone genes identified in the cattle genome among public databases
UniProt1
Genome2 Nucleic3 Complete Fragment TrEMBL Unreported4
Complete UniGene 56 3 16 6
DNA 1 0 0 2
Unreported 1 2 0 3
Fragment UniGene 1 0 0 0
Pseudogene 1 0 0 0
Not found Unreported 0 0 0 1
1 Derived from information provided in the corresponding UniProt release; Complete indicates the complete prohormone is present in the 
SwissProt database, Fragment indicates a partial sequence in the SwissProt database, and TrEMBl indicates a complete sequence without 
experimental data is reported in the TrEMBL database.
2 Complete, Fragment and Not found denote if the prohormone gene was completely recovered, partially recovered or there were no matches 
from the cattle genome, respectively.
3 Denotes the resource supporting the presence of the prohormone sequence in the cattle genome: UniGene, DNA (nucleotide and EST sequences 
not present in UniGene), pseudogenes and unreported.
4 Not previously reported (predicted or empirically confirmed) in cattle.BMC Genomics 2009, 10:228 http://www.biomedcentral.com/1471-2164/10/228
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had four matches; interestingly, there are two members of
the calcitonin family in human, mouse and rat. Further
findings about the calcitonin family are discussed in the
forthcoming calcitonin family section.
Galanin-like peptide (GALP) pseudogene
The evidence for a cattle GALP pseudogene is due to a lack
of matches to cattle EST data and predicted gene structure.
The matching region of cattle genome BLAST match on
cattle chromosome 18 included the sequence
GWTLNSAGYLLGP, which is completely conserved across
mammalian GALP and the related galanin (GALA) genes.
The cattle GALA [SwissProt: P11242] has been previously
reported on cattle chromosome 29 and the match also
included a larger region that is only conserved across the
GALP sequences. Additional GALP matches to unassigned
contigs in the recent cattle genome assemblies were
detected using as query the human GALP  genomic
sequence (including exons and introns), but there was
insufficient coverage to recover a complete sequence. This
discovery is likely to correspond to a pseudogene because
no initiation codon was found (Dr. Steven Salzberg, Dr.
Liliana Florea and Finn Hanrahan, personal communica-
tion). A fragment of a sheep GALP prohormone sequence
that also matched the same genomic location (E-value <
0.15) has been previously reported ([Swiss-Prot:A2TEF1].
However, the reliability of the sheep sequence informa-
tion is questionable because the sheep GALP nucleic and
protein sequences were identical to the rat GALP nucleic
([GenBank:AF188491] and protein ([Swiss-
Prot:Q9QXQ6]) sequences, respectively.
Relaxin family
The relaxin family is a subfamily of the insulin family [35]
although the family member notation varies across spe-
cies. Human, mouse and rat have relaxin 1 (RLN1),
relaxin 3 (RLN3), insulin-like 3 (INSL3), insulin-like 5
(INSL5) and insulin-like 6 (INSL6), of which rat INSL5
has been reported as a pseudogene [35]. Cattle INSL3 and
INSL6 prohormone genes have been previously reported
and the complete sequences were also recovered from the
genome. The complete sequences for the genes INSL5
(supported by [Unigene:Bt.101509]) and RLN3  (sup-
ported by EST [GenBank:BI682322]) were recovered in
this study, although these genes have not previously been
reported in cattle.
A remarkable result is that there were no matches on the
cattle genome or on the cattle ESTs to any available mam-
malian  RLN1  sequence that was not attributable to
another member of the relaxin family. No matches to cat-
tle genome sequences or ESTs were identified using the
sheep relaxin-like pseudo-gene ([GenBank:S60580]; [38])
and the RLN1 protein and mRNA sequences from camel
([GenBank:AF254739]), dog ([SwissProt:Q9TRM8]),
horse ([SwissProt:P22969] and pig ([SwissProt: P01348]).
A search for RLN1 was conducted using the trace archives
from other species belonging to Cetartiodactyla clade.
There was a strong match (E-value < 10-100) to a relaxin-
like gene in the Vicugna vicugna (vicuña) that was very
similar to the camel sequence, as expected, since both spe-
cies are members of the Tylopoda subclade. In the Cetacea
subclade there was a strong match (E-value < 10-100) to the
Tursiops truncatus (bottlenosed dolphin). Except for a
match (E-value < 10-100) in the sheep trace archives for the
known pseudo-gene, there were no matches in any of the
Ruminantia species including various deer species (such
as red and fallow deer) and Antilocapra americana (prong-
horn).
To further elucidate the possible location of a cattle
relaxin 1 gene or genes, the human chromosome that con-
tains  RLN1  and the corresponding cattle chromosome
were compared. Human RLN1 is located on chromosome
9 between the INSL6 and chromosome 9 open reading
frame 46 (C9orf46) and the distance between these loci is
approximately 170K bp. Both INSL6  and  C9orf46  are
located on cattle chromosome 8 but are only approxi-
mately 35 K bp apart. These results strongly suggest that
the relaxin 1 gene has been lost from the cattle genome.
Calcitonin family
The composition of the calcitonin family is complex due
to gene duplication, alternative splicing, different nomen-
clature, pseudogenes and partial protein sequences. The
human, mouse and rat calcitonin family includes calci-
tonin or the calcitonin gene-related peptide 1 (CGRP-I or
alpha-type CGRP or CALCA) and calcitonin gene-related
peptide 2 (CGRP-II or beta-type CGRP or CALCB) genes.
Alternative splicing of CALCA, a human calcitonin pseu-
dogene (CALCP) [39] and three calcitonin-related pro-
teins in pig [40] have been reported.
A query of the calcitonin prohormone family resulted in
four matches on cattle chromosome 15 that spanned a
region of 500 Kbp. These matches were supported by ESTs
in four UniGene clusters; UniGene cluster Bt.29881
(including four ESTs), UniGene cluster Bt.73268 (includ-
ing 1 EST), UniGene cluster Bt.14302 (including 11 ESTs),
UniGene cluster Bt.60861 (including 6 ESTs) and Uni-
Gene cluster Bt.28622 (including 5 ESTs). Two of the
matches were also supported by three UniProt TrEMBL
calcitonin-related records with complete gene sequences
in cattle: CALCB ([Swiss-Prot:Q17Q98]), calcitonin recep-
tor-stimulating peptide-1 ([Swiss-Prot:Q75V95]), and cal-
citonin-related polypeptide 3 or CALC3  ([Swiss-
Prot:Q0VBW3]). There is strong evidence suggesting that
[Swiss-Prot:Q17Q98] and [Swiss-Prot:Q75V95] are the
result of alternative splicing. The first 75 amino acids of
these two sequences are identical, there is substantialBMC Genomics 2009, 10:228 http://www.biomedcentral.com/1471-2164/10/228
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overlap of the corresponding genomic sequences, and
both prohormone genes were predicted from the same
genomic region using Wise2.
A third calcitonin family match in the cattle genome cor-
responded to a complete cattle calcitonin gene ([Swiss-
Prot:B5UBG1]) that contains the previously reported
calcitonin peptide ([Swiss-Prot:P01260]), a complete
sheep calcitonin gene ([Swiss-Prot:P01261]), and the
UniGene cluster Bt.14302. A prohormone gene was recov-
ered by Wise2 using the sheep sequence and the genomic
region of the UMD_1.5 assembly. The same protein
sequence was also obtained using two human calcitonin
variants ([GenBank:NP_001029124] and [Gen-
Bank:NP_001732]). A different sequence was obtained
from the same region using another human calcitonin
variant ([GenBank:NP_001029125]), suggesting that this
gene could undergo alternative splicing. This region also
had a strong match to the human calcitonin pseudogene,
implying that this calcitonin gene was present before the
evolutionary split that ultimately originated the human
and cattle species.
The last cattle genome match of the calcitonin family cor-
responded to UniGene cluster Bt.60861, that was associ-
ated with a predicted gene ([GenBank:XP_001253111]).
The predicted gene contained the domain associated with
the Calc_CGRP_IAPP gene superfamily. The goat calci-
tonin receptor-stimulating peptide-2 ([Swiss-Prot:
B3IWF8]) provided the best BLAST match (E-value < 10-
28) followed by the cattle CALC3 (E-value < 10-27) to this
predicted cattle gene. Although the genomic region is
homologous to the other matches, there is no candidate
prohormone gene that shows sufficient homology to the
predicted gene.
Prohormone gene expression across tissues and 
developmental stages
A census of the expression of 62 prohormone genes avail-
able in UniGene offered a first glimpse of the cattle tran-
script profiles. The most frequently expressed
prohormone genes (and percentage of reports) were
adrenomedullin (ADM; 7%), insulin-like growth factor 2
(IGF2; 7%), apoptosis-inducing, TAF9-like domain 1
(APITD1; 5%), esophageal cancer-related gene 4 protein
(ECRG4; 5%), secretogranin II (SCG2; 5%), platelet-
derived growth factor alpha polypeptide (PDGFA; 4%),
proenkephalin (PENK; 4%), proopiomelanocortin
(POMC; 4%), chromogranin B (CHGB; 3%), endothelin 1
(EDN1; 3%), TOR2A (3%), and somatostatin (SST; 3%).
The UniGene expression reports were almost equally dis-
tributed across the three developmental stages (fetus, calf
and adult) with the fetus and adult having the highest and
lowest number of reports, respectively. There were 26 tis-
sues or body sites that exhibited expression of at least one
prohormone gene. Most reports of tissues or body sites
(and percentage of reports across tissues) were in the brain
(12%), kidney (12%) intestine (8%), extraembryonic tis-
sue (7%), ovary (7%) and liver (6%). The distribution
across tissues and developmental stages reflects the lim-
ited experiments and microarray platforms used. The lack
of Unigene expression reports for other prohormone
genes are most likely due to incomplete study of cattle
neuropeptide genes across tissues and stages.
Microarray analysis
The analysis of the expression levels of prohormone gene
reporters from two cattle microarray experiments indi-
cated that all prohormone genes present in the platform
were detected [see Additional file 2]. Two prohormone
genes, platelet-derived growth factor beta polypeptide
(PDGFB) and cortistatin (CORT) were significantly (False
Discovery Rate adjusted P-value < 0.05) differentially
expressed in both studies. In the liver study, cows with
ketosis had a 27% higher fold change in PDGFB levels and
a 50% lower fold change in CORT than healthy cows. In
the placentome study, IVF embryos had a 45% higher
expression of PDGFB compared to AI embryos, but there
were no significant differences between NT and either AI
or IVF embryos. For CORT, NT embryos had at least a 50%
fold decrease in expression compared to both AI and IVF,
but there was no significant difference between AI and
IVF. The findings on PDGFB  confirm reports of high
expression levels in the placenta and the important role of
this growth factor in stimulating adjacent cells to grow
[41]. The expression of CORT in a subset of GABAergic
cells in the cortex and hippocampus has been associated
with synaptic transmission, and furthermore, CORT binds
to somatostatin receptor subtypes and inhibits cAMP [42].
Six prohormone genes, apelin (APEL), chromogranin A
(CMGA),  EDN1, insulin (INS), neuromedin B (NMB),
and tachykinin 3 (TAC3), were significantly differentially
expressed only in the placentome study. Nineteen prohor-
mone genes, ADM, natriuretic peptide precursor type C
(ANFC), ECRG4, gastrin (GAST), ghrelin/obestatin pre-
propeptide (GHRL), motilin (MOTI), arginine vaso-
pressin (AVP), neuropeptide FF-amide peptide (NPFF),
NPY, pyroglutamylated RFamide peptide (QRFP),  PPY,
proprotein convertase subtilisin/kexin type 1 inhibitor
(PCSK1N),  PDGFA, prodynorphin (PDYN), prolactin
releasing hormone (PRRP), PYY, CHGB, SCG2, and SST
were differentially expressed only in the liver study. Of the
remaining 25 prohormone genes, nine had differential
expression for other non-embryo type factors in the pla-
centome study. The expression of the CALCA, glucagon
(GCG), and osteocrin (OSTN) prohormone genes in the
placentome study and natriuretic peptide precursor type A
(NPPA) in the liver study failed to surpass the expression
level of the background, indicating that these prohor-BMC Genomics 2009, 10:228 http://www.biomedcentral.com/1471-2164/10/228
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mone genes were either not expressed or were present in
quantities too low to be reliably detected.
Proprotein convertases
It is critical to assess the presence of proprotein or prohor-
mone convertase enzymes that cleave the prohormone
proteins in the cattle genome because a change in these
proteases could affect the presence or abundance of a neu-
ropeptide. The mammalian proprotein convertase com-
plement includes furin (FURIN), proprotein convertase
subtilisin/kexin type 1 (PCSK1), proprotein convertase
subtilisin/kexin type 2 (PCSK2), proprotein convertase
subtilisin/kexin type 4 (PCSK4), proprotein convertase
subtilisin/kexin type 5 (PCSK5), proprotein convertase
subtilisin/kexin type 6 (PCSK6), proprotein convertase
subtilisin/kexin type 7 (PCSK7), proprotein convertase
subtilisin/kexin type 9 (PCSK9) and membrane-bound
transcription factor peptidase site 1 (MBTPS1) [1,12].
Only the cattle PCSK1 ([SwissProt:Q9GLR1]) and PCSK2
([SwissProt:Q9GLR0]) sequences are available. In this
study, the complete sequences of FURIN, PCSK1, PCSK4,
PCSK5, PCSK7, MBTPS1 and the 7B2 or secretogranin V
gene (SCG5), which is essential for PCSK2 function [43-
45], were recovered using the same approach as the pro-
hormone discovery. The complete PCSK2  and  PCSK6
sequences could not be recovered in the Btau_3.1 assem-
bly but were recovered in the Btau_4.0 assembly. Table 2
provides supporting evidence for the presence of the pro-
protein convertases based on records in the Entez Gene,
Unigene and UniProt databases. A partial match of 70 res-
idues to the human PCSK9  protein sequence of 690
amino acids was detected but subsequent searches in the
cattle EST and trace archives did not support the presence
of cattle PCSK9. Utilizing the information of the introns
and exons from human PCSK9, the chromosomal region
containing that contained the partial match was found to
contain multiple stop codons in different reading frames,
suggesting that this gene has been lost from the cattle
genome (Dr. Steven Salzberg, Dr. Liliana Florea and Finn
Hanrahan, personal communication).
Prohormone cleavage prediction
The prohormone cleavage prediction models developed
by Tegge et al. [17] were applied to 44 newly identified
prohormone genes with complete sequences. These
sequences excluded the 41 cattle prohormone genes used
to develop the cleavage prediction models [17]. Although
there were 34% more sites in the new prohormone genes
than in the prohormone genes used to develop the predic-
tive models (831 sites compared to 621 sites), the correct
classification rate of sequence positions into cleaved and
non-cleaved sites was over 86% and the area under the
receiver operating characteristic curves was over 76%
(Table 3). The amino-acids-plus-properties models pro-
vided slightly more true-positive predictions (predicted
cleavage sites that were confirmed by empirical data) but
slightly more false-positive predictions (predicted cleav-
ages sites that have not yet been reported) than the amino-
acids-only models. The artificial neural networks pro-
vided slightly higher correct classification rates than the
logistic regression models.
The cleavage prediction models were useful in evaluating
the differences between prohormone sequences predicted
from the genome information and those reported in the
literature or databases like UniProt. The sequences of 14
prohormone genes detected in the genome differed from
previously reported sequences. While these were not used
in comparing model performance, these sequence differ-
ences resulted in 35 locations with a basic amino acid that
had a different probability of prediction of cleavage
between the published and predicted sequences. How-
ever, the differences in probability of cleavage were typi-
cally 0.1 or lower and none of these differences resulted in
a different prediction of cleavage.
Conclusion
Neuropeptides are essential regulators of biological proc-
esses including development and growth. The release of
the cattle genome sequence has provided a unique oppor-
tunity to improve our knowledge of cattle neuropeptides
Table 2: Inventory of the cattle prohormone convertases across multiple repositories
Entrez Gene Symbol Entrez Gene Full Name Entrez Gene ID Unigene Cluster Accession Number1
FURIN furin (paired basic amino acid cleaving enzyme) 281374 Bt.21338 Q28193
PCSK1 proprotein convertase subtilisin/kexin type 1 281967 Bt.5562 Q9GLR1
PCSK2 proprotein convertase subtilisin/kexin type 2 281968 Bt.5563 Q9GLR0
PCSK4 proprotein convertase subtilisin/kexin type 4 508744 Bt.77029 XP_585571
PCSK5 proprotein convertase subtilisin/kexin type 5 528098 Bt.91475 XP_606509
PCSK6 proprotein convertase subtilisin/kexin type 6 524684 Bt.62498 XP_603014
PCSK7 proprotein convertase subtilisin/kexin type 7 515398 Bt.62043 XP_869877
SCG5 secretogranin V (7B2 protein) 508224 Bt.65187 Q2HJG0
MBTPS1 membrane-bound transcription factor peptidase, site 1 511682 Bt.18986 Q08E55
1 UniProt or GenBank accession number.BMC Genomics 2009, 10:228 http://www.biomedcentral.com/1471-2164/10/228
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so influential in many biological processes. This first
genomic survey of the prohormone gene complement in
cattle was conducted using an integrated bioinformatics
approach that combines empirical and inferred genomic,
transcriptomic and proteomic information to achieve a
comprehensive characterization of the cattle neuropeptid-
ome. This approach was able to address and resolve com-
plications that arise from alternative splicing, differential
processing of the prohormone, and non-neuropeptide
genes that hinder the experimental confirmation and
functional characterization of neuropeptides. The cattle
neuropeptide census was complemented with a genome-
wide characterization of prohormone gene expression
profiles and prediction of prohormone cleavage sites that
could result in neuropeptides.
Complementary bioinformatic searches of genome and
EST resources identified 92 cattle prohormone genes and
one prohormone gene not found in the cattle genome.
The understanding of the neuropeptide gene complement
was substantially advanced because 28 out of the 92 pro-
hormone genes either had no prior experimental evidence
at the protein level or only the nucleotide sequence was
available, and 9 prohormone genes lacked EST data.
Several findings at the genomic and transcriptomic levels
are notable. The bioinformatics approach uncovered a
putative TAC4 gene that has not been reported in cattle
and the isoform of the cattle TOR2A gene that contained
the putative cattle alpha- and beta-salusin neuropeptides.
The integrated strategy also uncovered a potential novel
duplication in the calcitonin family and galanin-like pseu-
dogene. There were no matches on the cattle genome for
the known mammalian relaxin 1 gene, indicating that this
gene has been lost in the cattle genome. The complete
sequences for genes INSL5 and RLN3 recovered in this
study have not previously been reported in cattle. With
the exception of PCSK9, all of the proprotein convertase
enzymes that cleave the proprotein sequences were
located in the cattle genome, suggesting that PCSK9 has
been lost from the cattle genome.
The available EST expression information offered an
introductory view to the expression patterns of prohor-
mone genes. Of the 62 prohormone genes that have
expression reports, ADM  and  IGF2  were the most fre-
quently reported. This information was complemented
with investigation of the expression profile of prohor-
mone genes in two different microarray studies. The anal-
ysis of these studies confirmed the association between
prohormone gene expression patterns and reproductive
and nutritional processes. There were 8 prohormone
genes differentially expressed among placentomes from
different embryo types and 21 prohormone genes were
differentially expressed in the liver of cows under different
nutritional levels.
Available logistic and artificial neural network models
had high accuracy (86% correct classification rate) in pre-
dicting the cleavage sites of prohormone sequences that
result in peptides. The performance was particularly out-
standing considering that these models were developed
on independent data not used to evaluate the prediction
accuracy. Models that include all prohormone data avail-
able are being developed. These models will constitute a
powerful tool to annotate prohormones on other species
related to cattle but without genome sequence informa-
tion or extensive empirical data to support the develop-
ment of models. Cattle prohormone gene sequences and
neuropeptide prediction approaches are available at http:/
/neuroproteomics.scs.uiuc.edu/neuropred.html. This
resource will facilitate the functional characterization of
the neuropeptides in cattle and related species with no
genome sequence and/or limited neuropeptide studies.
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